Evidence map›Paper›PMID 30021106›Full record

ArticleBiophysical journal2018

Single Proteoliposome High-Content Analysis Reveals Differences in the Homo-Oligomerization of GPCRs.

Samuel M Walsh, Signe Mathiasen, Sune M Christensen, Jonathan F Fay, Christopher King, Davide Provasi, Ernesto Borrero, Søren G F Rasmussen, Juan Jose Fung, Marta Filizola and 4 more

Abstract read
In one paragraph

Article in Biophysical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Oligomerization of G protein-coupled receptors: Still doubted?Progress in molecular biology and translational science · 2020
    Review
  12. Review
  13. GPCR homo-oligomerization.Current opinion in cell biology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Samuel M WalshBionanotechnology and Nanomedicine Laboratory, Department of Chemistry, University of Copenhagen, Copenhagen, Denmark.
Signe MathiasenBionanotechnology and Nanomedicine Laboratory, Department of Chemistry, University of Copenhagen, Copenhagen, Denmark.
Sune M ChristensenBionanotechnology and Nanomedicine Laboratory, Department of Chemistry, University of Copenhagen, Copenhagen, Denmark.
Jonathan F FayDepartment of Biochemistry and Biophysics, University of North Carolina Medical School, Chapel Hill, North Carolina.
Christopher KingProgram in Molecular Biophysics, Johns Hopkins University, Baltimore, Maryland.
Davide ProvasiDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Ernesto BorreroDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Søren G F RasmussenDepartment of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Juan Jose FungDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Palo Alto, California.
Marta FilizolaDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Kalina HristovaProgram in Molecular Biophysics, Johns Hopkins University, Baltimore, Maryland.
Brian KobilkaDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Palo Alto, California.
David L FarrensDepartment of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon.
Dimitrios StamouBionanotechnology and Nanomedicine Laboratory, Department of Chemistry, University of Copenhagen, Copenhagen, Denmark. Electronic address: stamou@nano.ku.dk.

Funding

BIOLOGICAL BASES OF DRUG-SEEKING BEHAVIORT32DA007262 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 1991 to 2022
$9.4M
TRAINING IN PHARMACOLOGY OF DRUGS OF ABUSET32DA007135 · NIDA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI DEVI, LAKSHMI A · 1985 to 2018
$4.9M
Biophysical approaches to investigate the biological significance of GPCR dimersR01DA038882 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FILIZOLA, MARTA · 2015 to 2019
$1.7M
Structural Aspects of Oligomerization in the Function of GPCRsK02DA026434 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FILIZOLA, MARTA · 2009 to 2018
$1.2M
Opioid Sensitive GABA inputs to the Ventral MidbrainR01DA034388 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 2012 to 2016
$967k
Crystallization and Structural Analysis of the Human Cannabinoid Receptor CB1R21DA043001 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI FARRENS, DAVID L · 2017 to 2018
$424k
NIDA NIH HHS K02 DA026434NIDA NIH HHS R01 DA034388NIDA NIH HHS R01 DA038882NIDA NIH HHS R21 DA043001NIDA NIH HHS T32 DA007135NIDA NIH HHS T32 DA007262
6 · The paper itself

Abstract

G-protein-coupled receptors (GPCRs) control vital cellular signaling pathways. GPCR oligomerization is proposed to increase signaling diversity. However, many reports have arrived at disparate conclusions regarding the existence, stability, and stoichiometry of GPCR oligomers, partly because of cellular complexity and ensemble averaging of intrareconstitution heterogeneities that complicate the interpretation of oligomerization data. To overcome these limitations, we exploited fluorescence-microscopy-based high-content analysis of single proteoliposomes. This allowed multidimensional quantification of intrinsic monomer-monomer interactions of three class A GPCRs (β

Indexed as

Protein MultimerizationLigandsProtein Structure, QuaternaryProteolipidsReceptors, G-Protein-CoupledSignal TransductionSolubilityLigandsProteolipidsproteoliposomesReceptors, G-Protein-Coupled

Identifiers

PMID30021106
PMCPMC6050755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.